NCT05584462 is a clinical trial in Diabetic Gastroparesis, sponsored by Assiut University.

Who is sponsoring NCT05584462?

NCT05584462 is sponsored by Assiut University.

What condition does NCT05584462 study?

NCT05584462 studies Diabetic Gastroparesis.

Is NCT05584462 still recruiting?

NCT05584462 is currently not yet recruiting. Last updated 17 January 2023.

Last reviewed 2023-01-17 · How we verify

NCT05584462

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gastroparesis in type2 Diabetic Patient

Not yet recruiting Last updated 17 January 2023

What this trial tests

trial in Diabetic Gastroparesis in 100 participants. Not yet recruiting.

Timeline

1 November 2023

Primary endpoint
1 January 2026

1 January 2027

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 November 2023
Primary completion	1 January 2026
Estimated completion	1 January 2027

Conditions studied

Diabetic Gastroparesis — all drugs for Diabetic Gastroparesis →

Sponsor

Assiut University

Who can join

Adults 40 to 70, any sex, with Diabetic Gastroparesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gastroparesis is defined by objective delaying of gastric emptying without any evidence of mechanical obstruction. Diabetic gastroparesis is a potential complication that occurs in the setting of poorly controlled diabetes, resulting from dysfunction in the coordination and function of the autonomic nervous system, neurons, and specialized pacemaker cells (interstitial cells of Cajal, ICC) of the stomach and intestine, and the smooth muscle cells of the gastrointestinal tract

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetic Gastroparesis

Currently open trials in the same condition.

NCT04661215 — Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms · recruiting
NCT07324785 — Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis · recruiting
NCT05273788 — Thoracic Neuromodulation for Diabetic Gastroparesis · Phase 1 · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05584462 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 17 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05584462.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing